Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders

Ahles, 2018, Cognitive effects of Cancer and Cancer treatments, Annu Rev Clin Psychol, 14, 425, 10.1146/annurev-clinpsy-050817-084903 Lange, 2019, Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors, Ann Oncol Off J Eur Soc Med Oncol, 30, 1925, 10.1093/annonc/mdz410 Buchbinder, 2018, Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and quality of life working committee of the CIBMTR and complications and quality of life working party of the EBMT, Bone Marrow Transplant, 53, 535, 10.1038/s41409-017-0055-7 Harrison, 2021, Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms, Oncologist, 10.1002/onco.13867 Koll, 2020, Screening for cognitive impairment in older adults with hematological malignancies using the Montreal cognitive assessment and neuropsychological testing, J Geriatr Oncol, 11, 297, 10.1016/j.jgo.2019.11.007 Williams, 2016, What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research, Br J Haematol, 174, 835, 10.1111/bjh.14211 Guida, 2019, Measuring aging and identifying aging phenotypes in cancer survivors, J Natl Cancer Inst, 111, 1245, 10.1093/jnci/djz136 Wildes, 2019, Geriatric assessment in older adults with multiple myeloma, J Am Geriatr Soc, 67, 987, 10.1111/jgs.15715 Jensen, 2021, Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status, J Geriatr Oncol Palumbo, 2011, Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival, Clin Cancer Res an Off J Am Assoc Cancer Res, 17, 1253, 10.1158/1078-0432.CCR-10-1925 Kumar, 2008, Improved survival in multiple myeloma and the impact of novel therapies, Blood, 111, 2516, 10.1182/blood-2007-10-116129 Wefel, 2011, International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol, 12, 703, 10.1016/S1470-2045(10)70294-1 Nasreddine, 2005, The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment, J Am Geriatr Soc, 53, 695, 10.1111/j.1532-5415.2005.53221.x Basch, 2016, Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial, J Clin Oncol, 34, 557, 10.1200/JCO.2015.63.0830 Henneghan, 2021, Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group, J Natl Cancer Inst, 10.1093/jnci/djab027 Rajkumar, 2015, Guidelines for determination of the number of prior lines of therapy in multiple myeloma, Blood, 126, 921, 10.1182/blood-2015-05-647636 Lin, 2018, Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience, Bone Marrow Transplant, 53, 1184, 10.1038/s41409-018-0151-3 Root, 2018, Pre-transplant cognitive dysfunction in hematologic cancers, predictors and associated outcomes, Biol Blood Marrow Transplant, 24, S291, 10.1016/j.bbmt.2017.12.354 McDowell, 2019, A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy, Radiother Oncol, 131, 179, 10.1016/j.radonc.2018.09.012 Katzman, 1983, Validation of a short orientation-memory-concentration test of cognitive impairment, Am J Psychiatry, 140, 734, 10.1176/ajp.140.6.734 Jayani, 2019, Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer, J Geriatr Oncol, 11, 284, 10.1016/j.jgo.2019.10.004 Nakamura, 2020, Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer, Psychooncology, 29, 1366, 10.1002/pon.5433 Cella, 2010, The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008, J Clin Epidemiol, 63, 1179, 10.1016/j.jclinepi.2010.04.011 Valentine, 2019, Construct validity of PROMIS® cognitive function in cancer patients and noncancer controls, Heal Psychol Off J Div Heal Psychol Am Psychol Assoc, 38, 351 Jensen, 2017, United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer, J Clin Oncol Off J Am Soc Clin Oncol, 35, 1913, 10.1200/JCO.2016.71.4410 Fieo, 2016, Measurement equivalence of the patient reported outcomes measurement information system(®) (PROMIS(®)) applied cognition - general concerns, short forms in ethnically diverse groups, Psychol Test Assess Model, 58, 255 Rothrock, 2019, Establishing clinically-relevant terms and severity thresholds for patient-reported outcomes measurement information system(®) (PROMIS(®)) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setti, Qual Life Res an Int J Qual Life Asp Treat Care Rehabil, 28, 3355, 10.1007/s11136-019-02261-2 Aaronson, 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, J Natl Cancer Inst, 85, 365, 10.1093/jnci/85.5.365 Cocks, 2011, Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30, J Clin Oncol Off J Am Soc Clin Oncol, 29, 89, 10.1200/JCO.2010.28.0107 Ramsenthaler, 2016, Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis, Eur J Haematol, 97, 416, 10.1111/ejh.12790 Giesinger, 2020, Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research, J Clin Epidemiol, 118, 1, 10.1016/j.jclinepi.2019.10.003 Pergolotti, 2019, Mental status evaluation in older adults with cancer: development of the mental health Index-13, J Geriatr Oncol, 10, 241, 10.1016/j.jgo.2018.08.009 HealthMeasures Loprinzi, 1994, Prospective evaluation of prognostic variables from patient-completed questionnaires. North central Cancer treatment group, J Clin Oncol, 12, 601, 10.1200/JCO.1994.12.3.601 Fillenbaum, 1981, The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire, J Gerontol, 36, 428, 10.1093/geronj/36.4.428 Podsiadlo, 1991, The timed “up & go”: a test of basic functional mobility for frail elderly persons, J Am Geriatr Soc, 39, 142, 10.1111/j.1532-5415.1991.tb01616.x Shumway-Cook, 2000, Predicting the probability for falls in community-dwelling older adults using the timed up & go test, Phys Ther, 80, 896, 10.1093/ptj/80.9.896 Center for Disease Control and Prevention, 2016 Guerard, 2017, Frailty index developed from a cancer-specific geriatric assessment and the association with mortality among older adults with cancer, J Natl Compr Canc Netw, 15, 894, 10.6004/jnccn.2017.0122 Ávila-Funes, 2009, Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study, J Am Geriatr Soc, 57, 453, 10.1111/j.1532-5415.2008.02136.x Hurria, 2005, Developing a cancer-specific geriatric assessment, Cancer, 104, 1998, 10.1002/cncr.21422 Wagner, 2009, Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy – cognitive function instrument, J Support Oncol, 7, W32 Hutchinson, 2012, Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review, Cancer Treat Rev, 38, 926, 10.1016/j.ctrv.2012.05.002 Mehnert, 2007, The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy, Patient Educ Couns, 66, 108, 10.1016/j.pec.2006.11.005 Pullens, 2013, Chemotherapy and cognitive complaints in women with breast cancer, Psychooncology, 22, 1783, 10.1002/pon.3214 Ganz, 2013, Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance, J Natl Cancer Inst, 105, 791, 10.1093/jnci/djt073 Shilling, 2007, Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer, Eur J Oncol Nurs, 11, 6, 10.1016/j.ejon.2006.02.005 Bender, 2008, What do perceived cognitive problems reflect?, J Support Oncol, 6, 238 Kuba, 2019, The relationship between acceptance, fatigue, and subjective cognitive impairment in hematologic cancer survivors, Int J Clin Health Psychol, 19, 97, 10.1016/j.ijchp.2018.12.001 Janelsins, 2014, Prevalence, mechanisms, and management of cancer-related cognitive impairment, Int Rev Psychiatry, 26, 102, 10.3109/09540261.2013.864260 Wefel, 2015, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA Cancer J Clin, 65, 123, 10.3322/caac.21258 Campisi, 2011, Cellular senescence: a link between cancer and age-related degenerative disease?, Semin Cancer Biol, 21, 354 Sanoff, 2014, Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer, J Natl Cancer Inst, 106, 10.1093/jnci/dju057 Mandelblatt, 2018, Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study, J Clin Oncol Off J Am Soc Clin Oncol, 36, 10.1200/JCO.18.00140 Thibaud, 2020, Frailty score of older patients with haematological malignancies: unsuspected role of mild cognitive impairment, Br J Haematol, 190, 144, 10.1111/bjh.16469 Rockwood, 2004, Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging, J Gerontol A Biol Sci Med Sci, 59, 1310, 10.1093/gerona/59.12.1310 Crouch, 2021, Comorbidity, cognitive dysfunction, physical functioning, and quality of life in older breast cancer survivors, Support Care Cancer Off J Multinatl Assoc Support Care Cancer Mandelblatt, 2016, Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance), Cancer, 122, 3555, 10.1002/cncr.30208 Mir, 2020, Patient-reported cognitive complaints in older adults with gastrointestinal malignancies at diagnosis– results from the cancer & aging resilience evaluation (CARE) study, J Geriatr Oncol, 10.1016/j.jgo.2020.02.008 Hermelink, 2010, Two different sides of “chemobrain”: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psychooncology, 19, 1321, 10.1002/pon.1695 Jaremka, 2014, Cognitive problems among breast cancer survivors: loneliness enhances risk, Psychooncology, 23, 1356, 10.1002/pon.3544 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat Rev Neurosci, 9, 46, 10.1038/nrn2297 Patel, 2015, Inflammatory biomarkers, comorbidity, and neurocognition in women with newly diagnosed breast cancer, J Natl Cancer Inst, 107, 10.1093/jnci/djv131 Kesler, 2013, Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors, Brain Behav Immun, 30, S109, 10.1016/j.bbi.2012.05.017 Pomykala, 2013, The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer, Brain Imaging Behav, 7, 511, 10.1007/s11682-013-9243-2 Ganz, 2013, Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction?, Brain Behav Immun, 30, S99, 10.1016/j.bbi.2012.07.015 Hoogland, 2019, Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation, Brain Behav Immun, 10.1016/j.bbi.2019.04.008 Gilmore, 2021, Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists, Cancer, 128, 1101, 10.1002/cncr.34010 Cohen, 2016, Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy, Cancer, 122, 3865, 10.1002/cncr.30269 Ethun, 2017, Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology, CA Cancer J Clin, 67, 362, 10.3322/caac.21406